Grafa News and Videos — Page 189

Qualcomm (NASDAQ:QCOM) initiated a federal trial in Delaware to freeze royalty payments to Arm Holdings (NASDAQ:ARM) for up to five years over alleged contract breaches.

Crescent Biopharma (NASDAQ:CBIO) received FDA clearance for its Investigational New Drug application for CR-002, an antibody-drug conjugate being developed for advanced solid tumors.

Alterity Therapeutics (NASDAQ:ATHE) reported additional Phase 2 analyses showing ATH434 50 mg slowed functional decline in multiple system atrophy by approximately 52% compared with placebo at Week 52.

TeraWulf (NASDAQ:WULF) secured expanded electrical capacity to accelerate development at its Muskie Data Campus.

Datasea (NASDAQ:DTSS) released its full-year financial performance for the period ending June 30, 2026, highlighting improved profitability metrics alongside top-line adjustments.

Fathom Holdings (NASDAQ:FTHM) and Neighborhood Intelligence (NASDAQ:NXH) called off their planned corporate combination after respective boards reviewed current market valuations and shareholder feedback.

Gilat (NASDAQ:GILT) expanded its Latin American telecommunications footprint through a new agreement between its local Peruvian subsidiary and Peru's national telecommunications program, Pronatel.

Construction Partners (NASDAQ:ROAD) expanded its regional operating footprint by closing the acquisition of asphalt and construction assets from Tye, Texas-based J.H. Strain & Sons.

NeuroOne (NASDAQ:NMTC) reported unaudited preliminary financial figures for the fiscal fourth quarter and full-year period ending September 30, 2026.

Abbott (NYSE:ABT) received regulatory clearance from the U.S. Food and Drug Administration for major software capabilities connected to its implanted heart-monitoring platform.